These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1362587)

  • 21. Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease.
    Pearson SJ; Reynolds GP
    Neurosci Lett; 1992 Sep; 144(1-2):199-201. PubMed ID: 1436703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex.
    Beal MF; Matson WR; Storey E; Milbury P; Ryan EA; Ogawa T; Bird ED
    J Neurol Sci; 1992 Mar; 108(1):80-7. PubMed ID: 1385624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurochemical abnormalities in Huntington's disease].
    Korczyn AD; Eshel Y
    Harefuah; 1983 Apr; 104(8):353-5. PubMed ID: 6232180
    [No Abstract]   [Full Text] [Related]  

  • 24. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
    Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
    Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.
    Spokes EG
    Brain; 1980 Mar; 103(1):179-210. PubMed ID: 6102490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein abnormalities in Huntington's chorea.
    Iqbal K; Tellez-Nagel I; Grundke-Iqbal I
    Brain Res; 1974 Aug; 76(1):178-84. PubMed ID: 4276706
    [No Abstract]   [Full Text] [Related]  

  • 27. Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease.
    Guidetti P; Luthi-Carter RE; Augood SJ; Schwarcz R
    Neurobiol Dis; 2004 Dec; 17(3):455-61. PubMed ID: 15571981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral cation shifts and amino acids in Huntington's disease.
    Gramsbergen JB; Veenma-Van der Duin L; Venema K; Korf J
    Arch Neurol; 1986 Dec; 43(12):1276-81. PubMed ID: 2877650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [NO. and the central nervous system].
    Delwaide PJ
    Rev Med Liege; 1995 Jan; 50(1):24-6. PubMed ID: 7871283
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neurotransmitters in Huntington chorea (review)].
    Barkhatova VP; Larskiĭ EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain GABA levels in asymptomatic Huntington's disease.
    Reynolds GP; Pearson SJ
    N Engl J Med; 1990 Sep; 323(10):682. PubMed ID: 2143559
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased brain 3-hydroxykynurenine in Huntington's disease.
    Reynolds GP; Pearson SJ
    Lancet; 1989 Oct; 2(8669):979-80. PubMed ID: 2571888
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurochemical anatomy of movement disorders.
    Young AB; Penney JB
    Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease.
    Pépin J; Francelle L; Carrillo-de Sauvage MA; de Longprez L; Gipchtein P; Cambon K; Valette J; Brouillet E; Flament J
    Neuroimage; 2016 Oct; 139():53-64. PubMed ID: 27318215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
    Carolei A; Del Castillo G
    Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
    [No Abstract]   [Full Text] [Related]  

  • 36. Disease-related protein changes in purified neurons from Alzheimer's and Huntington's diseases.
    Selkoe DJ
    Trans Am Neurol Assoc; 1979; 104():70-4. PubMed ID: 162259
    [No Abstract]   [Full Text] [Related]  

  • 37. [Huntington's disease--review on neuroscientific approaches].
    Kanazawa I
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1815-25. PubMed ID: 6241961
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in brain level of neurotransmitters].
    Kanazawa I
    Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1148-52. PubMed ID: 1680945
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunoreactive somatostatin-28(1-12) is increased in Huntington's disease.
    Beal MF; Benoit R; Bird ED; Martin JB
    Neurosci Lett; 1985 May; 56(3):377-80. PubMed ID: 2862613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease.
    Heyes MP; Swartz KJ; Markey SP; Beal MF
    Neurosci Lett; 1991 Jan; 122(2):265-9. PubMed ID: 1827518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.